Effectiveness of homoeopathic medicines in symptomatic treatment of lumbar spondylosis

INTERVENTION: Intervention1: Individualised Homoeopathic Medicine: After enrollment patients are randomly allocated in two groups. Group A individualised homoeopathic medicine and Group B for placebo . for group A appropriate potentized individualised homoeopathic medicine will be administered in minimum dose in appropriate potency according to the need of the case Medicine will be administered orally Repetition of the medicine and change of potency or remedy if required will be based on clinical assessment and homoeopathic principles during the follow up participants in the intervention arm will receive individualized homoeopathic medicine for a period of 6 months Control Intervention1: placebo: participants randomised to the control group will receive placebo identical in appearance in packing and will be administered orally for a period of 6 months The placebo will consist of saccharum lactis and will be administered according to the same dosing schedule as the intervention group Both participant and investigator responsible for outcome assessment will remain blinded Rescue medication will be permitted in both group as needed for intolerable pain The number of rescue medication dose consumed will be recorded throughout the study CONDITION: Health Condition 1: M479‐ Spondylosis, unspecified PRIMARY OUTCOME: Improvement will be measured using Modified Oswestry Disability Index which evaluate the pain intensity and activities of daily living to assess the functional disability of the patientTimepoint: Baseline, every month till 6month SECONDARY OUTCOME: VAS is use to assess the pain intensity of the patient during the period of treatmentTimepoint: Baseline, every month till6 months INCLUSION CRITERIA: 1.40‐70years both male and female 2.patient with clinical signs and symptoms of lumbar spondylosis 3.x‐ray showing radiological changes like osteophyte formation 4.narrowing of joint space